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CASE PRESENTATION
An 8-year-old boy from Karachi was referred to a 
hospital with a 4-month history of diffuse erythematous 
rash, generalized body ache, and fatigue. He was 
bedridden for the past two months. On examination, 
the child was fully oriented in time, place, and person. 
Child was drooling, dysphonic, and had impaired 
swallowing. Power in all limbs were 2/5, proximal 
muscle weakness was present, and there was partial 
neck holding. There was generalized swelling and an 
erythematous rash all over the body, but no ulcers or 
calcinosis were present. Abdominal, cardiovascular, 
and respiratory examinations were normal. 
Lab reports showed increased CPK of 2490 U/L, 
antinuclear antibody test was positive. Extractable 
nuclear antigen antibodies (ENA) panel was negative 
for systemic lupus erythematosus and juvenile 
idiopathic arthritis. Rheumatoid factor and anti-dsDNA 
antibody tests were negative. EMG studies were 
suggestive of irritable myopathy. MRI of quadriceps 
showed post-contrast enhancement of muscles, and 
biopsy from the left quadricep muscle was taken 
which showed perifascicular atrophy and necrosis, thus 
confirming the diagnosis of Juvenile dermatomyositis.
Management was initiated with nasogastric feeding and 
three doses of pulse Methylprednisolone (30mg/Kg), 
followed by subcutaneous Methotrexate (MTX) 
(15mg/m2) and hydroxychloroquine (HCQ) for 6 
months. Once stable, the child was discharged on 
physiotherapy. After one week of discharge, he 
presented again in the emergency department with 
severe respiratory distress. Examination and chest x-ray 
suggested right-sided lung collapse (Figure 1) due to 
excessive secretions. He required suctioning and 
mechanical ventilation. The next day, he developed 
hypertension with blood pressure exceeding 95th 
centile for his age (120/78 mmHg), vision loss and 
seizures. Cerebral fluid analysis and cultures were 
negative. MRI brain (figure 2) showed asymmetrical 
bilateral signals in the parieto-occipital regions that 
were hyperintense on T2 and flair images. These 
findings were consistent with the diagnosis of posterior 
reversible encephalopathy syndrome (PRES). The child 
was weaned off from ventilator after six days. However, 
due to his continued breathing and swallowing 
problems, tracheostomy and gastrostomy was done. 
Pharmacological treatment was escalated with two 
doses of I/V Immuno-globulin (2g/kg) followed by pulse 
Methylprednisolone for three doses. After discussion 
within a multidisciplinary team, MTX was replaced by 
intermittent Cyclophosphamide injections given every 
three weeks for six doses. 
The child was followed fortnightly, and he showed 
gradual improvement in vision and muscle strength. 
However, he required excessive suctioning due to 
copious secretions. To mitigate this problem, injection 
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INTRODUCTION
Juvenile dermatomyositis or JDM is a rare but debilitating pediatric disease that affects the proximal muscles and skin, 
as implied by its name. Although rare, it is the most common childhood idiopathic inflammatory myopathy (1). The 
estimated incidence is 3.2 cases per million children (2). The diagnosis is based on clinical signs and symptoms 
supported by investigations including, but not limited to, muscle biopsy, muscle enzymes and EMG studies. Bohan and 
Peter’s criterion is most widely used for diagnosis. It includes the presence of Gottron’s rash, raised muscle enzymes, 
proximal muscle weakness and suggestive findings on muscle biopsy (3). Treatment is done with a combination of 
steroid and immune-suppressing agents, mainly methotrexate (4).
This report illustrates a case of JDM that presented with Posterior Reversible Encephalopathy Syndrome (PRES) and 
vision loss which are unusual presentations among children. Only a handful of studies have been published in existing 
literature where children with JDM presented with neurological symptoms (5).
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Botox was administered in both parotid glands. At the 
end of six months, remission in the disease was noted. 
Rash had disappeared, muscle power had become 4 in 
all limbs, neck holding was complete, and vision had 
returned. Muscle enzymes also significantly decreased. 
The child was again shifted to subcutaneous MTX and 
HCQ. In his last follow up, the child could talk, was 
taking a significant amount of oral feed but could not 
walk. Tracheostomy and gastrostomy tubes were 
removed, MTX and HCQ were continued along with 
physiotherapy.
DISCUSSION
A large retrospective study consisting of 116 JDM 
patients was published by authors from France, 
wherein the most common complications identified 
were related to gastrointestinal tract (11/116), 
respiratory failure (1 patient), cardiac complications (1 
patient), thrombotic microangiopathy (2 patients). Only 
one child was found to have PRES (6). We reported an 
unusual neurological complication of JDM where the 
vasculopathic nature of this disease can be 
appreciated.
PRES, also known as Reversible Posterior 
Leukoencephalopathy Syndrome (RPLS), is a 
clinico-radiologic condition that presents with 
headache, encephalopathy, seizures, and vision 
abnormalities. On imaging it is seen as reversible 
vasogenic subcortical edema, most commonly in part 
supplied by posterior cerebral artery. Generally, 
pathophysiology of PRES is linked to hypertensive 
encephalopathy (7). While in JDM, complement system 
is responsible for causing PRES. Complement 
mediators attack the microvasculature and get 
deposited in endothelium of the vessels, leading to 
hypertension (8). We postulate that vasculitis and 
complement mediated injury was responsible for PRES 
in our child and hence he responded to 
immunosuppressive treatment. JDM associated 
neurological complications have been treated by 
immunosuppressants in other cases as well (5,6). 
However, our patient despite of having severe course of 
illness responded to treatment and recovered with 
disease sequalae. 
CONCLUSION
Dermatomyositis in children can present in various 
ways, and with severely debilitating associations. A 
timely diagnosis, appropriate treatment, and a high 
index of suspicion for associated conditions like PRES 
needs to be practiced for proper management.
FIG.1: Chest X-rays. Top: Right lung collapse due to 
excessive secretions. Bottom: Re-expansion of lungs 
after suctioning and ventilation.
FIG.2: MRI Brain. Left: T2 weighted axial image 
showing asymmetrical hyperintense signals in 
parieto-occipital region. Right: Flair coronal image 
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